X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (337) 337
Patent (11) 11
Publication (9) 9
Book Chapter (2) 2
Conference Proceeding (2) 2
Book Review (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (168) 168
index medicus (142) 142
endocrinology & metabolism (104) 104
type 2 diabetes (100) 100
male (93) 93
diabetes (90) 90
glucose (79) 79
female (74) 74
glucagon-like peptide-1 (71) 71
middle aged (71) 71
glucagon (70) 70
adult (63) 63
diabetes mellitus, type 2 - drug therapy (58) 58
insulin (56) 56
aged (49) 49
peptides (49) 49
diabetes mellitus, type 2 - blood (42) 42
blood glucose - metabolism (41) 41
hypoglycemic agents - therapeutic use (41) 41
diabetes mellitus, type 2 - metabolism (39) 39
gastric-inhibitory polypeptide (39) 39
diabetes mellitus (38) 38
glp-1 (38) 38
secretion (37) 37
care and treatment (36) 36
glucagon-like peptide 1 (32) 32
beta-cell function (30) 30
insulin - blood (29) 29
liraglutide (29) 29
research (29) 29
glucose tolerance test (28) 28
mellitus (28) 28
glucagon - blood (27) 27
obesity (27) 27
abridged index medicus (26) 26
dextrose (26) 26
insulin - metabolism (25) 25
glucagon-like peptide 1 - metabolism (24) 24
clinical trials (23) 23
glycemic control (23) 23
insulin secretion (22) 22
insulin-secretion (22) 22
physiology (22) 22
risk factors (22) 22
medicine, general & internal (21) 21
metabolism (21) 21
pharmacology & pharmacy (21) 21
analysis (20) 20
gastric inhibitory polypeptide - metabolism (20) 20
health aspects (20) 20
hyperglycemia (20) 20
physiological aspects (20) 20
young adult (20) 20
animals (19) 19
c-peptide - blood (19) 19
dependent insulinotropic polypeptide (19) 19
glucagon - metabolism (19) 19
insulin resistance (19) 19
metformin (19) 19
treatment outcome (19) 19
blood glucose - drug effects (18) 18
glucagon-like peptide 1 - therapeutic use (18) 18
healthy-subjects (18) 18
body mass index (17) 17
case-control studies (17) 17
diabetes mellitus, type 2 - complications (17) 17
double-blind method (17) 17
glucose-dependent insulinotropic polypeptide (17) 17
hypoglycemic agents - pharmacology (17) 17
patients (17) 17
association (16) 16
glucagon-like peptide 1 - analogs & derivatives (16) 16
glucagon-like peptide 1 - blood (16) 16
hypoglycemic agents - administration & dosage (16) 16
open-label (16) 16
oral glucose (16) 16
type-2 diabetes-mellitus (16) 16
glucagon-like peptide-1 receptor (15) 15
glucose metabolism (15) 15
diabetes mellitus, type 2 - physiopathology (14) 14
diabetics (14) 14
glucagon-like peptide 1 - pharmacology (14) 14
glycated hemoglobin a - analysis (14) 14
hypoglycemic agents (14) 14
hypoglycemic agents - adverse effects (14) 14
internal medicine (14) 14
plasma (14) 14
postprandial period (14) 14
cardiovascular disease (13) 13
denmark (13) 13
double-blind (13) 13
drug therapy (13) 13
gip (13) 13
hypoglycemia (13) 13
journal article (13) 13
blood glucose - analysis (12) 12
blood pressure (12) 12
body weight (12) 12
chemistry (12) 12
disease (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 19, pp. 1834 - 1844
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0166125
Objective Sodium-glucose co-transporter 2 inhibitors (SGLT2-i) are a novel drug class for the treatment of diabetes. We aimed at describing the maximal... 
ADD-ON THERAPY | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | LIVER-FUNCTION TESTS | SGLT2 INHIBITOR | MULTIDISCIPLINARY SCIENCES | DOUBLE-BLIND | CARDIOVASCULAR-DISEASE | METFORMIN PLUS SULFONYLUREA | JAPANESE PATIENTS | INADEQUATE GLYCEMIC CONTROL | LONG-TERM EFFICACY | Hypoglycemic Agents - therapeutic use | Sodium-Glucose Transporter 2 - metabolism | Glycated Hemoglobin A - metabolism | Humans | Sodium-Glucose Transporter 2 Inhibitors | Treatment Outcome | Diabetes Mellitus, Type 2 - metabolism | Randomized Controlled Trials as Topic | Diabetes Mellitus, Type 2 - blood | Canagliflozin - therapeutic use | Glucosides - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Type 2 diabetes | Medical research | Complications and side effects | Heart beat | Analysis | Glycosylated hemoglobin | Medicine, Experimental | Lipids | Glucose | Drug therapy | Dextrose | Diabetes therapy | Drugs | Genital tract | Pressure effects | Heart attacks | Liver | Bias | Body weight | Clinical trials | Cardiovascular disease | Systematic review | Infections | Cancer therapies | Blood | Confidence intervals | Quality | Hemoglobin | Blood pressure | Diabetes mellitus (non-insulin dependent) | Drug dosages | Creatinine | Glucose transporter | Alanine | Peptidase | Liver diseases | Kidneys | Diabetes mellitus | Data processing | FDA approval | Hypoglycemia | Metabolism | Patients | Heart rate | Studies | Hospitals | Inhibitors | Sodium | Ketoacidosis | Alanine transaminase | Metformin | Diabetes | Clinical medicine | Transporter
Journal Article
Diabetologia, ISSN 0012-186X, 2/2018, Volume 61, Issue 2, pp. 284 - 294
Journal Article
Journal Article